We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NMRA market cap is 1.47B. The company's latest EPS is USD -1.4849 and P/E is -6.22.
| Quarter End | Sep 2023 | ||
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | ||
| Operating Income | -56.86M | ||
| Net Income | -53.03M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -237.32M | -135.87M | -252.1M |
| Net Income | -237.31M | -130.9M | -235.93M |
| Quarter End | Sep 2023 | ||
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 544.75M | ||
| Total Liabilities | 32.06M | ||
| Total Equity | 512.69M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Assets | 429.3M | 426.23M | 496.2M |
| Total Liabilities | 24.66M | 29.4M | 27.12M |
| Total Equity | -325.22M | -446.85M | 469.08M |
| Market Cap | 1.47B |
| Price to Earnings Ratio | -6.22 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.93 |
| Price to Book Ratio | 3.13 |
| Dividend Yield | - |
| Shares Outstanding | 158.89M |
| Average Volume (1 week) | 588.87k |
| Average Volume (1 Month) | 630.73k |
| 52 Week Change | -43.94% |
| 52 Week High | 21.00 |
| 52 Week Low | 8.82 |
| Spread (Intraday) | 3.31 (27.58%) |
| Company Name | Neumora Therapeutics Inc |
| Address |
1209 orange street new castle, delaware |
| Website | https://www.neumoratx.com. |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
